Balyasny Asset Management
OKYO

Balyasny Asset Management’s OKYO Pharma OKYO Stock Holding History

Balyasny Asset Management’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$942K Buy
+584,796
New +$1.14M ﹤0.01% 2102

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Balyasny Asset Management's OKYO Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in OKYO Pharma (OKYO) in Q1 2026: 584,796 shares worth $942K. The stake represents ﹤0.01% of the portfolio and ranks #2102 among its holdings.

12 funds tracked by Wall St. Rank hold OKYO as of Q1 2026.

  • Balyasny Asset Management held 584,796 shares of OKYO Pharma worth $942K as of Q1 2026.
  • OKYO Pharma was a new Balyasny Asset Management position in Q1 2026.
  • OKYO Pharma made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2102 holding.
  • 12 funds tracked by Wall St. Rank held OKYO Pharma as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.